A multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of…
Read More »RSV
Respiratory syncytial virus (RSV) is the leading cause of hospitalization in young children due to respiratory complications such as bronchiolitis…
Read More »
Carina Marquez, an associate professor of medicine at the University of California, San Francisco, is a big believer in prevention.…
Read More »The complex shape of respiratory syncytial virus is one hurdle limiting the development of treatments for an infection that leads…
Read More »
Medicare Part D covers the vaccine for RSV, or respiratory syncytial virus, and generally there’s no cost to you. Here’s…
Read More »Vaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, hospitalizations, lost quality of life…
Read More »Irish scientists led by a group from Trinity College Dublin have discovered how the dangerous Respiratory Syncytial Virus (RSV) defuses…
Read More »Vaccinating mothers against respiratory syncytial virus (RSV) during late pregnancy to protect their newborns is not associated with an increased…
Read More »On the heels of a shortage of nirsevimab for infant respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) prevention,…
Read More »:max_bytes(150000):strip_icc()/GettyImages-2150746781-929619d26ff443759088583f0a1e078d.jpg?w=780&resize=780,470&ssl=1 "Moderna Stock Slips as FDA Delays RSV Vaccine Approval")
Key Takeaways Moderna said the Food and Drug Administration (FDA) has delayed its approval decision for the respiratory syncytial virus…
Read More »